Podcasts about dartmouth hitchcock

This DermSurgery Digest bonus content, aptly named “At the Microscope,” shares the latest research and techniques in dermatopathology. In this episode, we will review tumor upstaging related to basal cell carcinoma, squamous cell carcinoma and melanoma. Contributors to this podcast include Naomi Lawrence, MD, Dermatologic Surgery Digital Content Editor; Ashley Elsensohn, MD, MPH, DermSurgery Digest at the Microscope co-host; Christine Ahn, MD; Jeff Gardner, MD; Marina K. Ibraheim, MD; and Michael P. Lee, MD. Articles featured in this episode include: Pham D, Tabba D, Zhou C, Chow C, Elsensohn A. Histopathological discrepancy of biopsy specimens compared to subsequent Mohs surgery or wide local excision specimens. J Am Acad Dermatol. 2024 Sep;91(3):518-519. doi: 10.1016/j.jaad.2024.04.047. Epub 2024 Apr 27. PMID: 38685403. Link: https://pubmed.ncbi.nlm.nih.gov/38685403/Lim GF, Perez OA, Zitelli JA, Brodland DG. Correlation of basal cell carcinoma subtype with histologically confirmed subclinical extension during Mohs micrographic surgery: A prospective multicenter study. J Am Acad Dermatol. 2022 Jun;86(6):1309-1317. doi: 10.1016/j.jaad.2022.02.037. Epub 2022 Feb 26. PMID: 35231546. Link: https://pubmed.ncbi.nlm.nih.gov/35231546/Knackstedt TJ, Brennick JB, Perry AE, Li Z, Quatrano NA, Samie FH. Frequency of squamous cell carcinoma (SCC) invasion in transected SCC in situ referred for Mohs surgery: the Dartmouth-Hitchcock experience. Int J Dermatol. 2015 Jul;54(7):830-3. doi: 10.1111/ijd.12867. Epub 2015 Apr 27. PMID: 25920731. Link: https://pubmed.ncbi.nlm.nih.gov/25920731/Jackett LA, Gullifer JP, Scolyer RA. Evaluation of Multiple Tissue Levels Frequently Upstages Patients With Clinically Localized Thin Primary Cutaneous Melanoma. J Cutan Pathol. 2024 Oct 2. doi: 10.1111/cup.14726. Epub ahead of print. PMID: 39357975. Link: https://pubmed.ncbi.nlm.nih.gov/39357975/ Your feedback is encouraged. Please contact communicationstaff@asds.net.

‘Dartmouth-Hitchcock's epidemic that wasn't raises overlapping questions. If this could happen in one hospital, why not two? If two, why not four? If four, could the hospitals in an entire county or state be put on high alert, with staff isolated and vaccines distributed. And if the procedures put in place to deal with the epidemic actually started to cause harm, thereby confirming the epidemic is real - what's to stop the mass panic spreading over the entire globe?'   Faith in Quick Test Leads to Epidemic That Wasn't, New York Times: https://web.archive.org/web/20200806015144/https://www.nytimes.com/2007/01/22/health/22whoop.html   Measuring the Mandates:  https://www.deepstateconsciousness.com/measuring-the-mandates

Audible Bleeding editor Wen (@WenKawaji) is joined by 1st year vascular surgery fellow Richa Kalsi (@KalsiMD), 3rd year medical student Nishi (@Nishi_Vootukuru), 4th-year general surgery resident Sasank Kalipatnapu (@ksasank) from UMass Chan Medical School, JVS editor Dr. Forbes (@TL_Forbes), JVS-VLD associate editor Dr. Arjun Jayaraj and JVS social media liaison Dr. Haurani to discuss some of our favorite articles in the JVS family of journals.   This episode hosts Dr. Amy Felsted, Dr. Salvatore Scali, and Dr. Arjun Jayaraj, the authors of the following papers. Dr. Arjun Jayaraj and Dr. Haurani will also spend time discussing a virtual special issue, centered around iliofemoral venous stenting published in the Journal of Vascular Surgery, Venous and Lymphatic Disorders that includes six articles published between August 2023 and May 2024.    Articles: Part 1: A patient-centered textbook outcome measure effectively discriminates contemporary elective open abdominal aortic aneurysm repair quality by Dr. Felsted, Dr. Scali and colleagues.    Part 2: Virtual special issues on contemporary role of iliofemoral venous stenting    Show Guests  Dr. Amy Felsted (@aefelsted): Completed fellowship at Dartmouth-Hitchcock, Currently an assistant professor of surgery at Boston University School of Medicine and practicing vascular surgeon at the VA in Boston   Dr. Salvatore Scali: Professor of Surgery at University of Florida Division of Vascular Surgery and Endovascular Therapy, program director of the vascular fellowship at University of Florida.   Dr. Arjun Jayaraj: Vascular surgeon at the RANE Center in Jackson, Mississippi with a focus on the management of venous and lymphatic diseases, Associate Editor of JVS-VL.  Follow us @audiblebleeding Learn more about us at https://www.audiblebleeding.com/about-1/ and provide us with your feedback with our listener survey.

This episode's Community Champion Sponsor is Ossur. To learn more about their ‘Responsible for Tomorrow' Sustainability Campaign, and how you can get involved: CLICK HERE—Episode Overview: How can virtual care and innovative technology transform healthcare delivery? According to our next guest, Dr. Sarah Pletcher, it requires reimagining care models by leveraging cutting-edge solutions. As System Vice President and Executive Medical Director for Strategic Innovation at Houston Methodist, Dr. Pletcher leads the nationally renowned health system in developing and accelerating pioneering care strategies for the next decade.An accomplished surgeon and telehealth trailblazer, Dr. Pletcher shares her valuable insights on virtual nursing programs reducing burnout, wearables enhancing patient monitoring, expanding hospital-at-home offerings, implementing ambient AI for safety, and rolling out system-wide virtual rounding capabilities. Join us to learn how Dr. Pletcher is driving innovation at Houston Methodist, enhancing experiences and outcomes through tech-enabled, forward-thinking care delivery. Let's go!Episode Highlights:Pioneering virtual nursing programs that reduce burnout and retain staffLeveraging wearable sensors and remote monitoring to enhance patient careExpanding "hospital at home" and virtual care offerings to improve accessImplementing ambient AI and computer vision for safety and efficiencyRolling out system-wide virtual rounding capabilities in every patient room About our Guest:Dr. Sarah N. Pletcher is the System Vice President and Executive Medical Director for Strategic Innovation at Houston Methodist. In this role, she leads the health system on strategy, development, acceleration and execution of new care models and innovations that will move the health system into its next decade. Prior to joining Houston Methodist, Dr. Pletcher was the founder of the Centers for Connected Care & Telehealth at Dartmouth- Hitchcock, where she led the health system in the selection and implementation of new strategies utilizing telehealth technology platforms, and developed new clinical products and telemedicine programs across multiple specialties, and in multiple settings. This work includes a national scale telemedicine program which includes more than 60 specialties and six 24/7 hospital service lines, covering 100 hospitals across 10 states, and providing care through 20,000 patient encounters every month. As a consultant, Dr. Pletcher has advised health systems, policymakers, and investors about disruptive technologies and new business models that can provide value in serving populations. With over 25 years of healthcare innovation experience, she is frequently sought as a thought leader and invited speaker in areas of telemedicine, mhealth, innovation, clinical quality improvement, provider education and rural program development; and has been the principal investigator on over 15 million dollars of grant and foundational funding to advance these initiatives.Links Supporting This Episode:Houston Methodist website: CLICK HEREDr. Sarah Pletcher LinkedIn page: CLICK HEREHouston Methodist Twitter page: CLICK HEREMike Biselli LinkedIn page:

A new research paper was published in Oncotarget's Volume 13 on November 17, 2022, entitled, “Association of fall rate and functional status by APOE genotype in cancer survivors after exercise intervention.” Cancer treatment survivors often report impaired functioning and increased falls. Not all survivors experience the same symptom burden, suggesting individual susceptibilities. APOE genotype is a potential genetic risk factor for cancer treatment related side effects. Lifestyle factors such as physical activity can mitigate the effect of APOE genotype on measures of clinical interest in individuals without a history of cancer. In this new study, researchers Gwendolyn J. McGinnis, Sarah Holden, Betty Yu, Charlton Ransom, Carolyn Guidarelli, Brian De, K Diao, David Boyce, Charles R. Thomas Jr., Kerri Winters-Stone, and Jacob Raber from the University of Texas MD Anderson Cancer Center, Oregon Health and Science University and Dartmouth-Hitchcock's Dartmouth Cancer Center tested the hypothesis that APOE genotype influences cancer treatment related side effects and symptoms as well as response to exercise intervention. “In the current analyses, the modulating effect of apoE genotype on functional status and symptom burden in response to exercise intervention was investigated in a subsample of trial participants.” Data from a subsample of a study of fall prevention exercise in post-treatment female cancer survivors aged 50–75 years old (https://clinicaltrials.gov NCT01635413) were used to conduct a secondary data analysis. ApoE genotype was determined by serum sampling. Physical functioning, frequency of falls, and symptom burden were assessed using survey instruments. Data from 126 female cancer survivors a median of 49 months out from cancer diagnosis were analyzed. ApoE4 carriers trended toward a higher fall rate at baseline (p = 0.059), but after exercise intervention had a fall rate lower than E4 non-carriers both immediately after structured intervention (p = 0.013) and after 6 months of follow up (p = 0.002). E2 carriers did not show improved measures of depressive symptoms and self-report disability after exercise intervention. E3 homozygotes showed increased self report physical activity after the 6 month exercise intervention, but E4 and E2 carriers did not. “The study findings suggest that APOE genotype may be associated with presence and severity of cancer treatment-related side effects and symptoms and also influence the response to exercise-based interventions in cancer survivors.” DOI: https://doi.org/10.18632/oncotarget.28310 Correspondence to: Jacob Raber - raberj@ohsu.edu Video: https://www.youtube.com/watch?v=CvN9ZDWymz8 Keywords: apoE, breast cancer, exercise intervention, fall rate, functional status About Oncotarget: Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science. To learn more about Oncotarget, visit Oncotarget.com and connect with us on social media: Twitter – https://twitter.com/Oncotarget Facebook – https://www.facebook.com/Oncotarget YouTube – www.youtube.com/c/OncotargetYouTube Instagram – https://www.instagram.com/oncotargetjrnl/ LinkedIn – https://www.linkedin.com/company/oncotarget/ Pinterest – https://www.pinterest.com/oncotarget/ LabTube – https://www.labtube.tv/channel/MTY5OA SoundCloud – https://soundcloud.com/oncotarget For media inquiries, please contact: media@impactjournals.com

Joanne Conroy, M.D. is the CEO and President of Dartmouth Health. She was also recently elected by the American Hospital Association (AHA) to be their chair-elect designate. Prior to Dartmouth-Hitchcock, Dr. Conroy served as CEO of Lahey Hospital and Medical Center (formerly the Lahey Clinic). She also served as Chief Health Care Officer of the Association of American Medical Colleges. Dr. Conroy received her undergraduate degree in chemistry from Dartmouth College and an M.D. from the University of South Carolina.  Key Insights:Dr. Conroy discusses her new role with the American Hospital Association and her overarching vision for leadership in healthcare. Work Force Challenges. One of the AHA's top issues is the work force. There has been a significant decrease in healthcare workers across the country and we need to be creative about building pipelines for new workers as well as initiatives for retention.COVID-19's Lasting Impact. There are two silver linings from the pandemic. First is the expansion of telehealth. COVID-19 vastly accelerate the timeline for telehealth adoption and use. Second is the growth in remote work. Remote options give organizations a recruiting advantage, allowing them to select from a national pool of applicants. Equity of Opportunity. To develop the next generation of women leaders requires developing leadership training and programing to identify future leaders, as well as creating opportunities for those people to demonstrate their leadership. Training isn't useful with the opportunity to apply it.  Relevant Links:Follow Dr. Conroy on TwitterRead “AHA Board Names Joanne M. Conroy, M.D., as Chair-Elect Designate”

Meet Dora Mills:Dora Mills, M.D. is the Chief Health Improvement Officer of MaineHealth. Previously, she was the Vice President for Clinical Affairs and Director for the Center of Health Innovation at the University ofNew England. She also served as the Medical Director of MaineCare, and the Director of Public  Health for the Maine State Government. Dr. Mills received a Bachelor's in Biology and Russian from Bowdin College, an M.D. from the University of Vermont, and a Master of Public Health from Harvard University.Key Insights:Dr. Mills' experience exemplifies the power of partnerships in healthcare and public health. • Words of Encouragement. One day in college, the head of the Biology Department  told Dr. Mills she should consider medical school. It was the first time someone  encouraged her to think about a medical career, and it gave her the confidence to  pursue one. Today, Dr. Mills tries to provide the same encouragement as a mentor. • Public-Private Partnerships. Maine achieved high levels of vaccination through  partnerships. Companies like L.L. Bean lent employees to staff vaccine clinics.Additionally, breweries and restaurants across the state hosted clinics, offering free  beer and food to those who got vaccinated. • Women in Public Service. Dr. Mills has seen many great women leaders, including  her sister, the current Governor of Maine. For women interested in running for  office, there are programs to help. And if you run for office, seek out advice, butmake sure to still be who you are and use your own voice. This episode is hosted by Joanne Conroy, M.D. She is a member of the Advisory Council for Her Story and serves as the CEO and President of Dartmouth-Hitchcock and Dartmouth-Hitchcock Health. 

Meet Amber Barnato, M.D.:Amber Barnato, M.D. is the John E. Wennberg Distinguished Professor and the Director of The Dartmouth Institute for Health Policy and Clinical Practice at the Geisel School of Medicine at Dartmouth. She is trained in two medical specialties, public health and preventive medicine, and hospice and palliative medicine. Dr. Barnato received a bachelor's from the University of California at Berkeley, an M.D. from Harvard Medical School, an MPH from the University of California at Berkeley, and an MS from Stanford University. Key Insights:Amber Barnato, M.D. explores how her medical career experiences led her to the focus of palliative and end-of-life care.  Expanding Horizons. Dr. Barnato took a year before medical school to be a research assistant and speech writer for Assistant Surgeon General Dr. McGinnis. That experience expanded her horizons, exposing her to the policy process, and Dr. McGinnis served a sponsor, improving her medical school candidacy.Path to Palliative Care. Dr. Barnato was morally distressed by the end-of-life care she saw in her general surgery internship, which lacked emotional support, conversations with family, and concerns over quality of life. After listening to a story about end-of-life care research on the radio, she decided she wanted to join the research effort herself. Next Steps for the Dartmouth Atlas. The Dartmouth Atlas focuses on overuse and unwarranted variation of healthcare. However, Dr. Barnato wants the Atlas to expand to underuse and unjust variation. She would like to see a focus on health equity.  This episode is hosted by Joanne Conroy, M.D. She is a member of the Advisory Council for Her Story and is the CEO and President of Dartmouth-Hitchcock and Dartmouth-Hitchcock Health. Relevant Links:Learn more about Dr. Barnato and her researchFollow Dr. Barnato on Twitter

Key Insights:Suzanne Barakat, M.D. experienced personal tragedy, and was forced to fight through her grief to combat islamophobia in medicine, media, and society. Reluctant Activist. Dr. Barakat's Brother, his wife, and her sister were murdered by a white supremacist for being Muslim. Additionally, two of Dr. Barakat's relatives were assassinated for their political activism and journalism, presumably by the Assad regime. Neither case received much media attention, and Dr. Barakat became a reluctant activist, fighting for media coverage and that the cases be investigated.Health and Human Rights Initiative. This initiative provides pro bono forensic medical evaluations for asylum seekers. Medical professionals perform a full physical exam and psychological evaluation to corroborate the stories of violence from asylum seekers. This process greatly increases the likelihood of obtaining asylum.What Leaders Can Do. Healthcare leaders have a responsibility to ensure that their workforce represents their patient demographic, this leads to better health outcomes and quality of care for patients. Additionally, leaders must play a role in making their staff feel valued and supported, and implement safe and anonymous ways to report violations. This episode is hosted by Joanne Conroy, M.D. She is a member of the Advisory Council for Her Story and is the CEO and President of Dartmouth-Hitchcock and Dartmouth-Hitchcock Health. Relevant Links:Learn more about the Health and Human Rights InitiativeWatch Dr. Barakat's TED talk: “Islamophobia killed my brother. Let's end the hate”

In this episode, Fabrizio Billi, Director of Orthopedic Research at Harbor-UCLA Medical Center, discusses six papers on Artificial Intelligence and Robotics as part of the 2022 DocSF Digital Orthopedics Conference in a two-part panel with experts in health tech and orthopedics. He is first joined by Peter Schilling, assistant professor of orthopedic surgery at Dartmouth-Hitchcock, and Thomas Peterson, director of UCSF Reach Informatics Core and the Laboratory for Digital and Computational Health Sciences in the Orthopedic Surgery Department. They discuss three papers on artificial intelligence used for prediction and optimization, the definition of the most appropriate machine learning models, and the role of synthetic data. They predict AI tools will make doctors' and clinicians' practices more manageable and help them make more accurate predictions in the future. For the second part of the panel, he is joined by Stefan Kreuzer, an orthopedic surgeon from Innovate Orthopedics in Houston, and Jennifer McCaney, a mechanical engineer innovator and Executive Director of UCLA Biodesign. They discuss three papers on surgery robotics, automation, and precision enhancement for recognition and improvement of gestures and movements. They predict that doctors will be able to create better delivery models with robotic solutions, improve implant design with 3D printing, increase precision and automate more surgical procedures.  Join this fantastic conversation about artificial intelligence and robotics at the 2022 DocSF Digital Orthopedics Conference, and learn how these tools can make practices easier and won't replace your jobs!

On MedAxiom HeartTalk, we are diving deeper with part two on the PEARLS Paper - a blueprint structural heart programs can use to optimize care. Host, Melanie Lawson, speaks with Elizabeth Perpetua, DNP, ACNP-BC, FACC, Patricia Keegan, DNP, NP-C, AACC, Roseanne Palmer, MSN, RN, and Susan Schnell, MSN, ACNP-BC, all co-authors of the paper. They share how their geographical challenges influenced their perspectives writing the paper and discuss practical steps that organizations can take now, to implement guidelines and care pathways for future crises.Guest Bios: Elizabeth Perpetua, DNP, ACNP-BC, FACC: Founder of Empath Health Services and faculty at University of Washington in Seattle – Dr. Perpetua led the efforts and development of the PEARLS paper and the first published study describing the Structural Heart Coordinator role and Coordination in the U.S. She is a Doctor of Nursing Practice with 15 years of experience in structural heart program development and research. She was the Director of the structural heart programs at Swedish Medical Center and University of Washington before starting her work in consulting and education. Dr. Perpetua has trained thousands of nurses, physicians, and administrators in structural heart disease. Patricia Keegan, DNP, NP-C, AACC: the original coordinator and nurse practitioner at Emory Healthcare with the PARTNER trial, now the Director of Strategic and Programmatic Initiatives across all of Emory Heart and Vascular (system-wide). Many areas of expertise including but not limited to structural heart, congenital heart disease, nurse-led sedation, minimalist approach, same day discharge, program efficiencies, quality improvement, and clinical program development. Roseanne Palmer, MSN, RN: the original coordinator and nurse leader at Dartmouth Hitchcock with the PARTNER trial, now the Program Manager for Structural Heart. Many areas of expertise including but not limited to structural heart, shared decision making, patient stated goals, crisis management including work with the Red Cross, clinical program development. Susan Schnell, MSN, ACNP-BC: the original coordinator and nurse practitioner at Columbia University Irving Medical Center at the time when TAVR was in the first-in-man experience in 2007 (REVIVAL trial, preceded the PARTNER trial). Sue is currently the Chief Operating Officer for Columbia HeartSource. Many areas of expertise including but not limited to structural heart and interventional cardiology, system wide healthcare quality improvement and change management, clinical program development.  Bonus Links:PEARLS Paper - Elsevier: https://www.sciencedirect.com/science/article/pii/S2474870622008089 PEARLS Paper Video Extras - TCT: https://www.tctmd.com/PEARLShttps://www.tctmd.com/videos/pearls-the-heart-team-in-action.6270320173001

Re-meet the Hosts:This episode showcases the Her Story Advisory Council. Ceci Connolly is the President & CEO of the Alliance of Community Health Plans. Joanne M. Conroy, M.D., serves as CEO and President of Dartmouth-Hitchcock and Dartmouth-Hitchcock Health. Kristi Ebong is the head of Partnerships and Market Development at Define Ventures. Julie L. Gerberding, M.D. is Chief Patient Officer and Executive Vice President at Merck. Sanjula Jain, Ph.D. is a co-founder of Think Medium and is an SVP of Market Strategy and Chief Research Officer at Trilliant Health.Key Insights:For young professionals starting their careers, to established leaders looking to refine their skills, Her Story is the show for you. We tell stories by women, for women, to expand the vision of what is possible in healthcare.Bringing Others Along. Ceci emphasizes that women leaders should play a role in supporting and advancing the next generation of leaders. (1:01)Women Together. Dr. Conroy describes how groups of female leaders can help each other find their purpose, create impact, and make meaningful goals a reality. (2:38)Competitive Advantage. Kristi points out that being a woman can be a competitive advantage in male-dominated fields, by providing an outside perspective on the industry. (5:42)Building Your Toolbox. Dr. Gerberding encourages leaders to think of their career as a toolbox – each experience should add a new tool. The more versatile you are, the more opportunities you will have long-term. (7:39)Navigating Healthcare. Dr. Jain describes how healthcare is a complex industry. Her Story explores the multitude of career paths within and associated with healthcare. (9:52)

A new healthcare pre-apprenticeship offers high school students the chance to prepare for a registered apprenticeship in one of three fields while working at Dartmouth Hitchcock in Lebanon and taking classes at River Valley Community College in Claremont. It's one of several partnerships and initiatives designed to address the healthcare worker shortage and open doors for students.

Cameron Hult of the Concord Police Department and Jaclynn Rodriguez, Executive Director, Friends of Norris Cotton Cancer Center and Interim Fund Raising Events Director, Children's Hospital at Dartmouth-Hitchcock. Cameron and Jaclynn discussed the upcoming CHAD Hockey game between Police and Fire at SNHU Arena in Manchester.

As we transition into our new normal of living with COVID-19. We envision a state where diagnostic tests and oral medications are readily available for the community with an overall goal of increasing access to life-saving treatments that need to be given quickly to be effective. Dr. Rebecca Wang, infectious diseases physician and medical co-director of the comprehensive antimicrobial program, and Craig Worby, infectious disease clinical pharmacist at Dartmouth-Hitchcock and co-director of the comprehensive antimicrobic program, walks us through currently available outpatient COVID-19 therapies. The information shared in this episode is meant for medical education and should not be considered as medical advice.

In this episode of the Med Inspired podcast I sit down with Dr. Evie Marcolini and disuss all things dizziness. Dr. Marcolini practices emergency medicine and neurocritical care at Dartmouth Hitchcock in Hanover, New Hampshire. She is a national and international speaker and faculty advisor to wilderness medicine interest groups at the University of Maryland and Yale. We discuss all things dizziness. From distinguishing central vs peripheral causes to the red flags of posterior stroke to the HINTS exam. WE also delve into some tips and tricks on how to perform a better neurological exam to asssesing the posterior circulation, and a common sense approach to risk stratifying dizziness. 

What we cover: Harvey shares his personal and professional background and how he became interested in working with this population The creation of the Gender Diverse Care Coalition of NH and understanding the offerings and opportunities for the community The definition of Gender Affirmative Care Common mental health struggles and risks within the LGBTQIA+ community How mental health providers can better support this population Resources for both listeners and mental health professionals to get involved How to reach Harvey: https://www.harveyfeldmancounseling.com https://genderdiversecarecoalitionnh.com/ harveyfeldmanlcmch@gmail.com Harvey Feldman (he/him) is a licensed clinical mental health counselor in the State of New Hampshire (#2128). He holds a Master's degree in counseling from Goddard College (Plainfield, Vermont) with a focus on clinical issues of gender and sexuality. Harvey is a member of the Community Advisory Board for Dartmouth Hitchcock's Transgender Health Program, and a founding member of the Gender Diverse Care Coalition of New Hampshire. Additionally, Harvey holds a Master's degree from Teachers College, Columbia University and an undergraduate degree from Smith College. We would love to connect with you! If you listen to this podcast, please hit the subscribe button so that you never miss an episode and share this podcast with your community and friends. Tag us so we can give a shout out and if you really enjoyed this episode, feel free to share the love and leave a review. The podcast officially has its own handle and page! Connect with us here: https://www.instagram.com/hillaryandchristina/ Check out Christina's website at: https://www.christinaennabe.com/. And as always, stay well!

Meet Marna Borgstrom:Marna Borgstrom is CEO of Yale New Haven Hospital and Yale New Haven Health. She started her career at Yale New Haven over 40 years ago, and advanced through positions of increasing responsibility in administration, management, and operations. In 2005, she was selected to serve as CEO, and after 17 years will be retiring in March of 2022. She received a Bachelor's in Human Biology from Stanford and a Master of Public Health from Yale University School of Medicine. Key Insights:Marna Borgstrom has decades of experience in healthcare. She reflects on her career journey and leadership, and shares what she will do next. Operations and Strategy Inform Each Other. Good healthcare leadership requires both operations and strategic expertise. Being a good operator requires the strategic foresight to innovate, and being a good strategist requires understanding the business. (5:00)How to Develop Talent. Marna shares that she spent at least 25% of her time as CEO on talent development. Yale New Haven created a Lean In group to promote mentorship for both women and men. This work strengthened company culture and promoted internal succession. (15:42)Is Retirement the End? Not for Marna! After 43 years at Yale New Haven, she is excited to leave the organization in good hands. She is working on becoming a career coach, taking bucket list tips, and continuing her volunteer work with the Connecticut Center for Arts and Technology (21:16)This episode is hosted by Joanne Conroy, M.D. She is a member of the Advisory Council for Her Story and is the CEO and President of Dartmouth-Hitchcock and Dartmouth-Hitchcock Health.Relevant Links:“YNHHS CEO Marna Borgstrom to retire in 2022”Read “Parting thoughts, advice from Yale New Haven Health's retiring CEO”Listen to “'It's Important to Have a Vision:' Retiring Yale New Haven Health CEO”

Host Lisa Miller is joined by Jason Vallee, PhD, VP at Cheshire Medical Center, Dartmouth-Hitchcock. Topics include the definition of the patient experience, the role of the JUSST model, and the potential impact of Press Ganey rankings that no hospital can afford. Jason also explains how the ‘'sprinkler experience'' informed his understanding of mapping the patient journey and why choosing the right language is vital to build patient trust. To stream our Station live 24/7 visit www.HealthcareNOWRadio.com or ask your Smart Device to “….Play HealthcareNOW Radio”. Find all of our network podcasts on your favorite podcast platforms and be sure to subscribe and like us. Learn more at www.healthcarenowradio.com/listen

John lived in a world where mental health wasn't recognized—until his son faced severe struggles with alcohol. Now, he talks to thousands of youth and parents with the goal of breaking the stigma clouding mental illness. He shares his journey here. *Support the Dartmouth-Hitchcock campaign which John Broderick leads*: https://www.dartmouth-hitchcock.org/about/react-awareness-campaign (also contains the 5-signs campaign). Data mentioned in the episode can be found at: https://www.healthaffairs.org/doi/10.1377/hlthaff.2016.0011 https://www.cdc.gov/childrensmentalhealth/data.html

COVID-19 cases, hospitalizations, and deaths continue to increase, driven by the Omicron variant making it more important for individuals to keep up-to-date with the most recent public health recommendations. However, keeping up with the ever changing guidelines is not only challenging for some but also confusing and frustrating given the many nuances that come with the changes. In this episode, host Jessica Swain, senior infection preventionist at Dartmouth Hitchcock, talks to Dr. Aalok Khole, infectious disease physician at Cheshire Medical Center, to help us navigate through the CDC's updated mask recommendations, & isolation and quarantine guidelines. Dr. Khole also walks us through how to interpret home antigen test results and shares highlights about new therapy against COVID-19 infection. The information shared in this episode is meant for medical education and should not be considered as medical advice.

Former New Hampshire Chief Justice and current mental health advocate, John Broderick joins Kathryn Wickersham to discuss all things mental health. The former chief justice vulnerably recounts his own experiences as a parent dealing with his son's mental health crisis. Broderick also gives advice on how we can destigmatize mental health, and signs to be on the look out for if you think someone close to you might be struggling. Trigger Warning: Talks of mental health struggles such as anxiety, depression, and suicide Resources: John Broderick's REACT campaign in partnership with Dartmouth Hitchcock: https://www.dartmouth-hitchcock.org/about/react-awareness-campaign The Reconnection Project: https://www.jefflevincoaching.com/the-reconnection-project/ If you or a loved one needs help: https://www.nimh.nih.gov/health/find-help Contacts: John Broderick- johntbroderickjr@gmail.com Jeff Levin- jeff@jefflevincoaching.com Fellsway Wanderers- fellswaywanderers@gmail.com

Meet Senator Jeanne Shaheen:Senator Jeanne Shaheen is the sitting U.S. Senator for New Hampshire. She is a member of the Senate Committees on Armed Services, Foreign Relations, Appropriations, Small Business and Entrepreneurship, and the Select Committee on Ethics. Previously, Sen. Shaheen served as the Director of Harvard University's Institute of Politics at the Kennedy School of Government. She was also elected Governor of New Hampshire, and is the first woman in U.S. history to be elected both a Governor and United States Senator.Key Insights:Senator Jeanne Shaheen is an accomplished politician. She is the highest-ranking woman on the Armed Services Committee, and has been an elected public servant for over two decades.Raise Your Hand. While at the Institute of Politics at the Kennedy School at Harvard, when she asked which student want to run for office, almost every male hand would go up, but only a third of women. Sen. Shaheen emphasizes the importance of having women in office, so policy decisions reflect women's experiences (4:42)Compromise. Reaching compromise requires a willingness to listen to other points of view, to find common ground, and to be respectful. (16:30)Public Service. For women interested in public service careers, Sen. Shaheen recommends that you reflect on what issues you care about most, and find related work. This is the best entrance into what you might want to do next in politics, policy, or public service. (17:51)This episode is hosted by Joanne Conroy, M.D. She is a member of the Advisory Council for Her Story is the CEO and President of Dartmouth-Hitchcock and Dartmouth-Hitchcock Health.Relevant Links:Learn more about Senator Shaheen's campaignFollow Senator Shaheen on Twitter“Partisan politics compromise the bipartisan consensus around energy efficiency” by Sen. Jeanne Shaheen 

See what's coming up on Her Story Season 3! Trailer features: Sen. Jeanne Shaheen (NH) Dana Udall, Chief Clinical Officer, Headspace Health Yasmeen Long, Director, Milken Institute, FasterCures Nimisha Kalia, M.D., Chief Medical Officer, GE Deena Shakir, Partner, Lux Capital Marna Borgstrom, Former CEO, Yale New Haven Health Season 3 hosts include: Joanne Conroy, M.D., President and CEO, Dartmouth-Hitchcock and Dartmouth-Hitchcock Health Ceci Connolly, President and CEO, Alliance of Community Health Plans Kristi Ebong, Head of Partnerships and Market Development, Define Ventures Julie Gerberding, M.D., Chief Patient Officer, Executive Vice President, Population Health & Sustainability, Merck Sanjula Jain, Ph.D., Co-founder, Think Medium; SVP, Market Strategy & Chief Research Officer, Trilliant Health Tune in for Her Story Season 3 on January 5th!

The omicron variant is now the predominantly circulating variant of concern in the United States. It is more transmissible and may have the ability of immune escape. Time will tell if it leads to a more severe disease, but regardless of disease severity, we need to remain vigilant and get the vaccine, get boosted, wear our masks, and wash our hands. These are all additive layers of protection to prevent the spread of infection. We are joined by Caitlin Adams Barker who is a senior infection preventionist at Dartmouth Hitchcock. We talk to Caitlin about how we can reduce the likelihood of transmission as we plan to spend time with family through the holidays. Dr. Justin Kim also joins us for this episode. He is the hospital epidemiologist at Dartmouth Hitchcock and he gives us some higlights about the omicron variant and novel therapies for COVID-19. The information shared in this episode is meant for medical education and should not be considered as medical advice.

"As I scientist I ask-- where's the data on COVID vaccines? How many women, how many men, how many shots? Which arm? Did it cause their diabetes to get better? Did it affect their time off of work? What kind of reaction? We need to know this." Renowned physician and executive Dr. James Weinstein is here, talking public health, policy, wasteful spending, and transparency— or lack of— in our medical system. Life can throw us medical curveballs, sometimes one after another. How is a patient, regardless of having healthcare or not, supposed to know what is best for him or her? Jim Weinstein's model, conceived at Dartmouth-Hitchcock Medical Center, is one he calls “informed choice.” Can doctors and patients work together to find a way to better decision-making? Where is the basic data on responses to mRNA vaccines that the public can access and look through? Why is public messaging often so muddled? With a deeply personal story interwoven with family tragedy and a wealth of expertise in the corporate and academic medical worlds, this is a unique perspective on the complex inner workings of the system most close to us all— our health. If you like what we do, please support the show. By making a one-time or recurring donation, you will contribute to us being able to present the highest quality substantive, long-form interviews with the world's most compelling people. Dr. James N. Weinstein joined Microsoft in July 2018 as Senior Vice President, Microsoft Healthcare, leading strategy, and innovation. During the pandemic, he has worked with Operation Warp speed and various organizations around the world, including, WHO, CDC as well as state and local government efforts to bring the Microsoft vaccine platform for enrolling, disseminating, and tracking vaccine participants. He serves as executive sponsor for some the largest health delivery systems in the world, including, NHS, HCA, CVS, MGB (the Harvard system), John's Hopkins, Centene, Kaiser and many others. Dr. James N. Weinstein is the immediate past Chief Executive Officer and President of Dartmouth-Hitchcock Health. The $2.5 billion system includes New Hampshire's only academic medical center and a network of affiliated hospitals and clinics across Vermont and New Hampshire, serving a patient population of about 2 million. Under his leadership, Dartmouth-Hitchcock worked to create a “sustainable health system” for the patients and communities it serves, for generations to come. As leader of a bi-state health system, he created an operating model based in population health locally and nationally. The 7 hospital system ranked in the top 1% for quality. He created a joint venture with Harvard Pilgrim to create a new health plan for Northern New England. He worked with Congress during three prior administrations, and helped lead the ACO, population-based strategies and led national efforts in Patient Reported Outcome Measures (PROM's) and Health Equity. In the past few years, he's helped lead the formation of the Advanced Regenerative Manufacturing Institute (ARMI), funded initially by an $80 million grant from the Department of Defense and more than $300 million in private sector funding. ARMI uses 3D technology to print human organs, a development that could transform the world of organ transplantation and the lives of millions affected by diseases such as kidney disease and diabetes. He is a member of the Board of Directors of ARMI/BioFab.

Holly Gaspar of Dartmouth-Hitchcock and Chelsie Rommell of NH Legal Assistance discuss a new medical-legal partnership being launched in the Upper Valley and Sullivan County. The two-year pilot project will identify health disparities in those communities and make civil legal assistance accessible to young families in need in those communities. This week's episode is sponsored by TFMoran (www.tfmoran.com), a leading land planning and engineering firm with offices in Bedford and Portsmouth, NH.

In this episode, We talk to Dr. Susanne Tanski, section chief and vice chair of pediatrics at Dartmouth-Hitchcock about the recently approved Pfizer-BioNtech COVID-19 vaccine for children ages 5 to 11 years old. She talks to us about the safety and efficay of the vaccines, how to weigh the risks and benefits, and what this means for our kids growth and development. The information shared in this episode is meant for medical education and should not be considered as medical advice.

On episode 107, Leon speaks with Dr. Rachel Zoffness about the medical history of pain management; how the opioid crises is fueled by a purely biological understanding of pain; the emotional, social, and biological components of pain; the neurological anatomy of pain; the unhealthy thoughts and actions associated with pain and how changing them helps us modulate it; why therapists often fear treating chronic pain; the negative correlation of opioid use, wherein opioids cause us to become more sensitized to pain as we become desensitized to them; why thoughts and emotions are physical and should be discussed in relation to our bodies; and the critical components of CBT for chronic pain. Dr. Rachel Zoffness is a Health and Pain Psychologist, international speaker, author, and thought-leader in pain medicine. She is an Assistant Clinical Professor at the UCSF School of Medicine, lecturer at Stanford, pain education faculty at Dartmouth-Hitchcock, and a 2021 Mayday Fellow. Dr. Zoffness was trained at Brown, Columbia, NYU, UCSD, and Mt. Sinai Hospital. Dr. Rachel Zoffness | ► Website | https://www.zoffness.com/ ► Twitter |  https://twitter.com/DrZoffness ► Instagram | https://www.instagram.com/therealdoczoff ► The Pain Management Workbook: https://amzn.to/3my4L5C Where you can find us: | Seize The Moment Podcast | ► Facebook | https://www.facebook.com/SeizeTheMoment ► Twitter | https://twitter.com/seize_podcast  ► Instagram | https://www.instagram.com/seizethemoment ► TikTok | https://www.tiktok.com/@seizethemomentpodcast

The COVID-19 pandemic continues to be one of the greatest challenges of modern medicine. Experts continue to do research on drugs that can help save lives of infected people and perhaps even prevent them from getting sick in the first place. In today's episode, we will be talking about updates on the treatment options for COVID-19. Host Jessica Swain, senior infection preventionist at Dartmouth-Hitchcock, is joined by Dr. Rebecca Wang Infectious Disease physician at Dartmouth Hitchcock Medical Center and medical co-director of the Comprehensive Antimicrobial Program. The information shared in this episode is meant for medical education and should not be considered as medical advice.

Guest Co-Host Robin deAlmeida, Project Director of Communications and Family Engagement at the Parent Information Center of New Hampshire, joins the show to talk about parenting and finding your family voice. And later, Dr. Erik Shessler, Pediatrician with Dartmouth-Hitchcock, discusses the intersection of family voice, the art of listening, and what good health care looks like.Support the showLISTEN on Spotify, Apple, or wherever you get your podcasts. Ask your smart speaker to play NH Family NOW!

Vermont's plan for back-to-school. Plus, Dartmouth-Hitchcock to require vaccines for employees, Vermonters in Tokyo, and remembering Elka Schumann.

C. difficile is a germ that causes severe diarrhea and inflammation of the colon. It's estimated to cause almost half a million infections in the United States each year and about one in six patients who get a C difficile infection will get it again in the subsequent two to eight weeks. In this episode, senior infection preventionist, Caitlin Adams Barker talks to Cameron Griffin who is an infection preventionist and chair of the C. difficile prevention committee at Dartmouth-Hitchcock and Dr. Michael Calderwood who is an infectious disease physician and the chief quality officer for Dartmouth Hitchcock about the treatment and prevention of C. difficile infections. The information shared in this episode is meant for medical education and should not be considered as medical advice.

*From time to time we'll re-air a previous episode of the show that our newer audience may have missed.* In this episode of Her Story hosted by Dr. Joanne Conroy, President and CEO of Dartmouth-Hitchcock, and Dartmouth-Hitchcock Health, we sit down with Kim A. Keck, President and CEO, Blue Cross Blue Shield Association. Joanne and Kim discussed how Kim's unconventional path ultimately led to her appointment as the first woman to serve as the Blue Cross Blue Shield Association's president and CEO since the organization was founded four decades ago.

Season 1 | Episode 22 | July 7, 2021In this week's episode, Dr. Trey Dobson hosts Jeffrey Parsonnet, MD, an infectious disease physician at Dartmouth-Hitchcock and the leader of a clinic designed to help people with enduring COVID symptoms. Dr. Parsonnet arrived at Dartmouth in 1990, having completed his Infectious Diseases (ID) training at Brigham and Women's/Beth Israel Hospital.  He is currently Professor of Medicine at Geisel School of Medicine and an attending physician in the ID Section at Dartmouth-Hitchcock Medical Center.  His research interests have included toxic shock syndrome and treatment of septic shock, and areas of special clinical interest include HIV infection, Lyme disease, and bone and joint infections.Underwriter: Mack Molding

Karen Clements believes that “being in healthcare is a lifelong learning event,” and we couldn't agree more. On the show today, Karen shares with us some of the most important lessons she has learned over the years, in the diverse range of settings she has worked in, including the army and a psychiatric hospital. Karen has received a number of well-deserved awards for her services, but she won't take the credit herself and attributes much of her success to the teams she has been surrounded by. Pride, compassion, and resiliency are the three core pillars on which Karen builds her life, and she explains how she lives these out, and how she helps her team members get through challenging times. Karen has a wealth of valuable knowledge to share about ways of improving communication channels between nurses and management, working with multigenerational teams, and how to deal with the curveballs that life will inevitably throw at all of us at some point. Karen also shares her thoughts on what she thinks the future of nursing will look like, and the main thing she wishes she could change in the healthcare industry. Karen's passion for her work is undeniable, and the world is lucky to have her as a CareHero. Key Points From This Episode:Why Karen would choose flying as her superpower. Karen's early introduction to the world of nursing. The trajectory of Karen's nursing career, from the army to her current position at Dartmouth-Hitchcock.  What Karen's job entails, and what she loves the most about it.Advice that Karen gives to the new graduates who come to work at her hospital.The succession plan for nurses that exists at Karen's hospital. Karen's journey of continuous learning. Accreditation that Karen's hospital received during the week this podcast was recorded. How Karen's time in the army equipped her for all the jobs she has held since then. A person who has had a hugely positive influence on Karen's life.Ways that you can improve your communication with management. Value that is being brought to the hospital by the millennial nurse mentor that Karen consults with.Lessons that Karen learned from working at a psychiatric hospital. Don't be afraid of the curveballs; what this means to Karen and why it is the best advice she has ever been given.Karen explains the action she took which led to her receiving an Above and Beyond Award.Ways that nurses make memorable differences in patients' lives. Pride, compassion, resiliency; the core pillars that Karen lives by. How Karen looks after her own mental health, and the mental health of her team. Karen shares her thoughts about the future of nursing. The biggest challenge that Karen sees in the healthcare sector. Links Mentioned in Today's Episode:LinkedInDartmouth-HitchcockThe Dartmouth Institute | For Health Policy & Clinical PracticeDAISY FoundationHealth Leaders Media ArticleUniversity of MaineHusson UniversityFACHE | American College of Healthcare Executives

In this episode, We talk to Dr. Lauren Gilstrap who is a heart failure and transplant cardiologist. Dr. Gilstrap walks us through cardiovascular risk factors associated with severe COVID-19 disease, acute and chronic cardiovascular complications of COVID-19, and the benefits of the vaccine for patients with heart disease. Marshall Ward, MD is a staff hospitalist and Associate Section Chief of Hospital Medicine at at Dartmouth-Hitchcock. Amogh Karnik, MD is a Chief Medical Resident at Dartmouth-Hitchcock. If you have any questions for us, drop us a line at thecure@hitchcock.org!

In this episode, Amogh and Marshall chat with Dr. Ellen Eisenberg, Interim Section Chief of General Internal Medicine and Associate Professor of Medicine at Geisel, and Dr. Jeffrey Parsonnet, attending Infectious Disease physician and Professor of Medicine at Geisel. They discuss the post-acute complications of COVID, and how DH-H is working to provide a new avenue for patients with long term symptoms after acute COVID-19 through a collaborative, multidisciplinary clinic. Patients can be referred to this clinic directly by their primary care providers. For more information about this program, contact postCOVID@hitchcock.org. Marshall Ward, MD is a staff hospitalist and Associate Section Chief of Hospital Medicine at at Dartmouth-Hitchcock. Amogh Karnik, MD is a Chief Medical Resident at Dartmouth-Hitchcock. If you have any questions for us, drop us a line at thecure@hitchcock.org!

In this episode, Amogh, Jose, and Rima chat with Dr. Richard Zuckerman. Dr. Zuckerman is an Infectious Disease specialist and the director of the Transplant and Immunocompromised Hosts Program at Dartmouth-Hitchcock. They review the data on tocilizumab, sarilumab, and other novel treatments that are being studied to treat COVID-19 infection. Rima Mercado, MD is a staff hospitalist and the Medical Director of the Medical Specialties Units at Dartmouth-Hitchcock Medical Center. Jose Mercado, MD is a staff hospitalist and Associate Hospital Epidemiologist at DHMC. Amogh Karnik, MD is a Chief Medical Resident at DHMC.

Ultrasound is essential in hospital medicine, but can it be used in wilderness and austere settings?  What are the advantages and what are the challenges of bringing ultrasound into the backcountry? Listen as  Nicholas Weinberg, MD, Johndavid (Jd) Storn, MD and Jennifer Wray from the Emergency Medicine Department at Dartmouth-Hitchcock discuss this exciting topic. 

Mahathi, Amogh, Marshall, and Jose sit down with John Dick, MD, a staff hospitalist at Dartmouth-Hitchcock and is the interim Associate Dean for Medical Education at the Geisel School of Medicine at Dartmouth (among many other things). They discuss the far-reaching impact of the COVID-19 pandemic on the medical education system as a whole, the role of students in the pandemic, and how medical education is looking to change as we look to the future.  Mahathi Komaragiri, MD is a staff hospitalist at Dartmouth-Hitchcock Health. Amogh Karnik, MD is a chief medical resident at DHMC. Marshall Ward, MD is a staff hospitalist and Associate Section Chief of Hospital Medicine at Dartmouth-Hitchcock. Jose Mercado, MD is also a staff hospitalist and is the Associate Hospital Epidemiologist at Dartmouth-Hitchcock.  Questions? Drop us a line at thecure@hitchcock.org!

This week, NH Business Review editor Jeff Feingold talks with the hosts of Dartmouth-Hitchcock's new COVID-19 podcast, The Cure, including Jose R. Mercado, MD, Rima Mercado, MD, Amogh Karnik, MD, and Marshall Ward, MD. The team discusses how the podcast aims to combat misinformation about COVID-19 and the vaccine, they break down the logistics of vaccine distribution in New Hampshire, and talk about the long term. This week's episode is sponsored by TFMoran (www.tfmoran.com), a leading land planning and engineering firm with offices in Bedford and Portsmouth, NH.

In this episode, Rima, Marshall, and Amogh chat with Dr. Gary Schwartz, a medical oncologist at Dartmouth-Hitchcock and Associate Professor of Medicine at the Geisel School of Medicine at Dartmouth. Dr. Schwartz sheds some light on the safety and efficacy of the available COVID-19 vaccines as it relates to patients with cancer on chemotherapy, immunotherapy, or radiation therapy. Rima Mercado, MD is the Director of the Medical Specialties Unit and a staff hospitalist at Dartmouth-Hitchcock Medical Center . Marshall Ward, MD is the Associate Section Chief of Hospital Medicine and a staff hospitalist at Dartmouth-Hitchcock. Amogh Karnik, MD is a chief medical resident at Dartmouth-Hitchcock. Questions? Drop us a line at thecure@hitchcock.org!

In this episode, Amogh, Marshall, and Rima check in with Dr. Deborah Ornstein, the director of the Hemophilia and Thrombosis Center at Dartmouth-Hitchcock. They discuss why COVID-19 seems to be associated with increased risk of blood clots and strategies for preventing clots in patients. Amogh Karnik, MD is a chief medical resident at Dartmouth-Hitchcock Medical Center. Marshall Ward, MD is Associate Section Chief of Hospital Medicine and a staff hospitalist at Dartmouth-Hitchcock. Rima Mercado, MD is unit director of the Medical Specialties Unit and is also a staff hospitalist at Dartmouth-Hitchcock. Questions? Drop us a note at thecure@hitchcock.org!

In this mini-episode, Marshall Ward, Mahathi Komaragiri, and Rima Mercado chat with Erin Reigh, an Allergy/Immunology specialist at Dartmouth-Hitchcock to get her perspectives on the vaccine and the risk of allergic reactions as we see our initial wave of vaccine distributed around the country. Questions? Drop us a line at thecure@hitchcock.org!

We're back after a long break for our semester programs.  Sorry for the wait, but we're glad to be back. In this episode, I'm joined by Nick Daniel of Dartmouth-Hitchcock in New Hampshire. Nick has taught AWLS courses regionally and internationally and has taught wilderness medicine in such locations as the Adirondacks, White Mountains, Mexico, Africa, Guatemala, Russia, and Panama. He spent a month in the Indian Himalayas teaching medical students while providing medical care, as well as time in Haiti. He has completed his FAWM and earned a diploma in mountain medicine. Nick's research interests in wilderness medicine include hypothermia, frostbite, altitude medicine, mountaineering psychology, and hiker preparedness. Recently, he and his coworkers from Dartmouth's wilderness and emergency medicine program came out to our campus for an introduction to wilderness living/survival skills.  Our conversation ranges from talking about Nicks's background and experience in the outdoors, the program for wilderness medicine fellowships at Dartmouth, as well as some insight into the psychology behind who finishes trips and who doesn't, and why that is.  I had a great time talking with Nick, and working with him on the course here at our campus in southern VT. I'm pretty sure you'll get a kick out of our conversation as well. If you like the podcast, please leave us a review, and to learn more about our programs please visit Schooloftheforest.comLinks;Deep Survival by Laurence GonzalesWilderness Medicine at Dartmouth Hitchcock

Hilary Ryder, MD, is an Associate Professor of Medicine and Medical Education and Director of the internal medicine residency program at Dartmouth-Hitchcock Medical Center. Dr. Ryder completed her medical school from Yale University School of Medicine and her internship and residency training in internal medicine at Dartmouth-Hitchcock before joining the faculty in the Section of Hospital Medicine where she focuses on end of life care, medical decision making and medical ethics. She is a nationally certified Health Care Ethicist and was the chair of the clinical ethics committee. Dr. Ryder has a keen interest in medical education and also served as Medical Editor for SIMPLE, the most widely used on-line, case-based third-year medical clerkship curriculum. Her current work focuses on meaning and understanding of assessments and evaluations, understanding how medical students learn (including mastery of hidden curriculum), and improving clinical systems to maximize education. When Dr. Hilary Ryder was in second grade, she refused to sit at a table with a child in her class that was bullying her. Her mom—her first mentor—sat with her in protest outside of the classroom until the bully was moved to a different table. It was there that Dr. Ryder experienced how mentors are advocates for mentees. When mentees are faced with obstacles that inhibit their learning or well-being, it is the role of the mentor to stand behind them in support until those obstacles are removed. Since then, Dr. Ryder has practiced supporting her mentees in the same way. When we face “stumbling blocks” in medicine, we can count on strong mentors to help us remove them—and realize our potential. Pearls of Wisdom: 1. Mentors help us remove our “stumbling blocks”. When obstacles come our way, good mentors stand behind us and help remove them, and then we realize our potential. 2. As Ruth Bader Ginsberg would say, “you can have it all in your lifetime, but you can't have it all at once.” Think critically about your core values, and your priorities, as you make decisions along the way. 3. The attitude of gratitude is a driving force for fulfillment. And realizing that we are so privileged to have been given so much so far, should push us to want to give back in return.

Dr. Ed Merrens is Chief Clinical Officer and a Hospitalist at Dartmouth-Hitchcock, Assistant Professor of Medicine at Dartmouth's Geisel School of Medicine, and Board Member of the U.S. Anti-Doping Agency (USADA). He shares his perspective on challenges in anti-doping, the impacts of COVID-19 on sport, and exciting developments in anti-doping. Ed also discusses his role on the Board of USADA and his experiences as a team physician for U.S. Biathlon and the U.S. Olympic and Paralympic Committee.

Dr. Joanne Conroy '77, CEO and President of Dartmouth-Hitchcock and Dartmouth-Hitchcock Health  talks about the coronavirus's arrival in the Upper Valley, her vision for the future of health care, and tells stories from her own time as a medical student. It's a conversation full of hope and reassurance. 

6:55 “If the Bible is sufficient, then why do we have a bookstore at our conference?” 8:50: “Are there any benefits in psychology that we can use to help the heart restoration of our broken counselees?” 13:26: “In light of recent events, how is you talking about the differences between biblical counseling and integration not speaking the truth in love?” 19:28: “Seven years ago I was having what seemed like focal seizures. I was tested by two neurologists and was told there was nothing wrong with me. I sought counseling from a NANC counselor who recommended more Bible study and that I should search to relieve these symptoms. My seizure activity continued and with the improvement of technology and an impatient week at Dartmouth-Hitchcock hospital, it was found that I've had a brain tumor and a frontal lobe epilepsy deep in my brain. The scans confirmed and clearly showed the medical evidence. Here is my question or concern with your ministry: for seven years I was told that I did not need medication, but that this was a spiritual issue. How can you really know if something is medical or not? My experience has left me with bitterness for NANC counseling when it comes to what are perceived as “mental issues.” Please provide input as our church is considering being a part of your ministry and I have some deep concerns. I do appreciate your counseling ministry and have seen wise and fruitful results for many.” 26:24: “Where is the best place to start with a new church that is trying to start biblical counseling within their church?” And we had another question that's similar: “How do you introduce biblical counseling to a church?” 29:36: “Do you feel that promoting certification creates an unnecessary bar for people who want to help other people by making them feel like they are not competent to counsel unless they have received extensive training?” 36:14: “What are some, if any, differences between ACBC and CCEF?” 38:39: “What is the role of women in biblical counseling?” 44:56: “Do you think there is a time for separation in marriage other than when there is imminent danger (i.e. emotional abuse, sexual addiction, etc.) and what would be your biblical defense for your position? If your answer is no, how would you suggest a woman can be best shepherded when extreme cases arise and there is much to sort out but there is not physical violence?” 51:02: Why would ACBC or the Bible not be supportive of trying to go and dig up suppressed memories? And if the person can't remember abuse, they need to try to figure out how can they be healed.” 53:46: “How can we discern whether someone suffering from a transgender identity (gender dysphoria) is struggling with mental illness, a physical disorder between the brain and the body present since birth, or a spiritual identity issue? These seem like real possibilities to me.” 59:15: “What is the theme of next year's conference?” 1:00:16: “How can people listen to this podcast on a weekly basis?”